CHU de Liege — Liège

Public research footprint of CHU de Liege, compiled from the ClinicalTrials.gov public registry.

135

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Crohn's Disease · Carcinoma, Non-Small-Cell Lung · Relapsed or Refractory Multiple Myeloma · Hidradenitis Suppurativa

Recently updated registry entries

NCT06012240 — A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and… (Recruiting)
NCT07230691 — A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell… (Recruiting)
NCT05242484 — A Study of Combination Therapy With Guselkumab and Golimumab in Participants With… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at CHU de Liege?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.